Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

The 5th edition of Manipal Hospital Old Airport Road's flagship workshop series, Handling Unexpected Emergencies (HUE), ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

LONDON - GSK plc (LSE/NYSE: GSK) has announced the acceptance of regulatory filings in China and Japan for depemokimab, a new biologic treatment for asthma with type 2 inflammation and chronic ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

Asthma is a chronic inflammatory disease that affects the lungs. In a child with asthma, the airways are very sensitive, ...

The Huntington County Health Department has handed out allergen-reducing mattress and pillow covers this week.

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

Dr. Sean Moran from Valley Baptist Medical Center in Harlingen spoke about how to keep safe during extreme winter weather. Dr. Moran talked about the most common ...

As wildfires continue to spread across the Los Angeles area, residents with asthma and other respiratory diseases face ...

Scientists at Rutgers Health have made a groundbreaking discovery that could transform how asthma is diagnosed and monitored.

The nation’s second largest city and its surrounding areas are now experiencing hazardous air quality - here's how these ...